Clinicopathological Predictors of Axillary Pathological Complete Response and Its Prognostic Significance in Clinically Node-Positive (cN+), HER2-Positive Breast Cancer Following Neoadjuvant Therapy.
Article in Medicina (Kaunas, Lithuania), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
14 authors.
Şahin BedirDepartment of Medical Oncology, Istinye University Faculty of Medicine, Gaziosmanpaşa Hospital, Istanbul 34250, Turkey.ORCID 0000-0002-5797-0804
Uğur Alp YeşilovaDepartment of Medical Oncology, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Istanbul 34480, Turkey.ORCID 0009-0005-8375-1575
Merve TokoçinDepartment of General Surgery, University of Health Sciences, Bagcilar Training and Research Hospital, Istanbul 34100, Turkey.ORCID 0000-0001-8040-300X
Burçin Çakan DemirelDepartment of Medical Oncology, Istanbul Medipol University, Medipol Mega University Hospital, Istanbul 34214, Turkey.ORCID 0000-0003-0734-0692
Yakup BozkayaDepartment of Medical Oncology, Istinye University Faculty of Medicine, Gaziosmanpaşa Hospital, Istanbul 34250, Turkey.
Abdilkerim OymanDepartment of Medical Oncology, Istinye University Faculty of Medicine, Gaziosmanpaşa Hospital, Istanbul 34250, Turkey.
Murad GuliyevDepartment of Medical Oncology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul 34098, Turkey.
Hamza AbbasovDepartment of Medical Oncology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul 34098, Turkey.ORCID 0000-0003-1227-9996
Nebi Serkan DemirciDepartment of Medical Oncology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul 34098, Turkey.
Ezgi DeğerliDepartment of Medical Oncology, University of Health Sciences, Bakırkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul 34147, Turkey.
Gamze UsulDepartment of Pathology, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Istanbul 34480, Turkey.ORCID 0000-0003-2264-8417
Ebru ŞenDepartment of General Surgery, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Istanbul 34480, Turkey.ORCID 0000-0002-0121-4540
Nilüfer BulutDepartment of Medical Oncology, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Istanbul 34480, Turkey.ORCID 0000-0002-2406-1946
Gökmen Umut ErdemDepartment of Medical Oncology, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Istanbul 34480, Turkey.ORCID 0000-0002-3375-9465
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Clinicopathological Predictors of Axillary Pathological Complete Response and Its Prognostic Significance in Clinically Node-Positive (cN+), HER2-Positive Breast Cancer Following Neoadjuvant Therapy. · full record | OpenQuestion